vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Loar Holdings Inc. (LOAR). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $131.8M, roughly 1.6× Loar Holdings Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 9.5%, a 47.9% gap on every dollar of revenue.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
IDYA vs LOAR — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $131.8M |
| Net Profit | $119.2M | $12.5M |
| Gross Margin | — | 52.1% |
| Operating Margin | 52.2% | 18.0% |
| Net Margin | 57.4% | 9.5% |
| Revenue YoY | — | 19.3% |
| Net Profit YoY | 330.1% | 239.5% |
| EPS (diluted) | $1.33 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $131.8M | ||
| Q3 25 | $207.8M | $126.8M | ||
| Q2 25 | — | $123.1M | ||
| Q1 25 | — | $114.7M | ||
| Q4 24 | — | $110.4M | ||
| Q3 24 | $0 | $103.5M | ||
| Q2 24 | $0 | $97.0M | ||
| Q1 24 | $0 | $91.8M |
| Q4 25 | — | $12.5M | ||
| Q3 25 | $119.2M | $27.6M | ||
| Q2 25 | — | $16.7M | ||
| Q1 25 | — | $15.3M | ||
| Q4 24 | — | $3.7M | ||
| Q3 24 | $-51.8M | $8.7M | ||
| Q2 24 | $-52.8M | $7.6M | ||
| Q1 24 | $-39.6M | $2.2M |
| Q4 25 | — | 52.1% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 53.8% | ||
| Q1 25 | — | 52.1% | ||
| Q4 24 | — | 48.9% | ||
| Q3 24 | — | 51.1% | ||
| Q2 24 | — | 49.0% | ||
| Q1 24 | — | 48.4% |
| Q4 25 | — | 18.0% | ||
| Q3 25 | 52.2% | 22.9% | ||
| Q2 25 | — | 22.2% | ||
| Q1 25 | — | 22.8% | ||
| Q4 24 | — | 19.2% | ||
| Q3 24 | — | 22.1% | ||
| Q2 24 | — | 22.9% | ||
| Q1 24 | — | 23.3% |
| Q4 25 | — | 9.5% | ||
| Q3 25 | 57.4% | 21.8% | ||
| Q2 25 | — | 13.6% | ||
| Q1 25 | — | 13.4% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 8.4% | ||
| Q2 24 | — | 7.9% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | — | $0.13 | ||
| Q3 25 | $1.33 | $0.29 | ||
| Q2 25 | — | $0.17 | ||
| Q1 25 | — | $0.16 | ||
| Q4 24 | — | $-11023.48 | ||
| Q3 24 | $-0.60 | $0.09 | ||
| Q2 24 | $-0.68 | $0.09 | ||
| Q1 24 | $-0.53 | $11023.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $84.8M |
| Total DebtLower is stronger | — | $715.7M |
| Stockholders' EquityBook value | $1.1B | $1.2B |
| Total Assets | $1.2B | $2.0B |
| Debt / EquityLower = less leverage | — | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.8M | ||
| Q3 25 | $786.9M | $99.0M | ||
| Q2 25 | — | $103.3M | ||
| Q1 25 | — | $80.5M | ||
| Q4 24 | — | $54.1M | ||
| Q3 24 | $920.0M | $55.2M | ||
| Q2 24 | $701.7M | $73.2M | ||
| Q1 24 | $698.8M | $28.2M |
| Q4 25 | — | $715.7M | ||
| Q3 25 | — | $279.4M | ||
| Q2 25 | — | $277.7M | ||
| Q1 25 | — | $277.5M | ||
| Q4 24 | — | $277.3M | ||
| Q3 24 | — | $602.1M | ||
| Q2 24 | — | $250.7M | ||
| Q1 24 | — | $534.2M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $1.2B | $769.8M | ||
| Q2 24 | $931.7M | $758.4M | ||
| Q1 24 | $935.3M | $420.6M |
| Q4 25 | — | $2.0B | ||
| Q3 25 | $1.2B | $1.5B | ||
| Q2 25 | — | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $1.2B | $1.5B | ||
| Q2 24 | $973.7M | $1.1B | ||
| Q1 24 | $961.5M | $1.1B |
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 0.25× | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | 0.78× | ||
| Q2 24 | — | 0.33× | ||
| Q1 24 | — | 1.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $30.4M |
| Free Cash FlowOCF − Capex | $142.2M | — |
| FCF MarginFCF / Revenue | 68.4% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 1.19× | 2.43× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $30.4M | ||
| Q3 25 | $142.2M | $29.7M | ||
| Q2 25 | — | $23.8M | ||
| Q1 25 | — | $28.4M | ||
| Q4 24 | — | $20.7M | ||
| Q3 24 | $-49.2M | $16.3M | ||
| Q2 24 | $-32.9M | $7.1M | ||
| Q1 24 | $-43.8M | $10.8M |
| Q4 25 | — | — | ||
| Q3 25 | $142.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-49.7M | — | ||
| Q2 24 | $-33.9M | — | ||
| Q1 24 | $-45.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | 68.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 2.43× | ||
| Q3 25 | 1.19× | 1.08× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 1.85× | ||
| Q4 24 | — | 5.62× | ||
| Q3 24 | — | 1.89× | ||
| Q2 24 | — | 0.93× | ||
| Q1 24 | — | 4.81× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
LOAR
| Other | $76.8M | 58% |
| Commercial Aerospace | $21.2M | 16% |
| Business Jet And General Aviation | $17.6M | 13% |
| Defense | $16.2M | 12% |
